Revolution Medicines Inc [RVMD] stock prices are up 5.25% to $43.07 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The RVMD shares have gain 4.69% over the last week, with a monthly amount drifted -2.58%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Revolution Medicines Inc [NASDAQ: RVMD] stock has seen the most recent analyst activity on July 16, 2024, when Needham reiterated its Buy rating and also boosted its price target to $62 from $46. Previously, Barclays started tracking the stock with Overweight rating on July 12, 2024, and set its price target to $52. On July 08, 2024, Jefferies initiated with a Buy rating and assigned a price target of $63 on the stock. Needham reiterated its Buy rating and increased its price target to $46 on April 12, 2024. Raymond James upgraded its rating to a Strong Buy and raised its price target to $48 on April 10, 2024. Piper Sandler started tracking with a Overweight rating for this stock on March 11, 2024, and assigned it a price target of $43. In a note dated January 05, 2024, BofA Securities upgraded an Buy rating on this stock and boosted its target price from $31 to $34.
The stock price of Revolution Medicines Inc [RVMD] has been fluctuating between $27.40 and $62.40 over the past year. Currently, Wall Street analysts expect the stock to reach $67.67 within the next 12 months. Revolution Medicines Inc [NASDAQ: RVMD] shares were valued at $43.07 at the most recent close of the market. An investor can expect a potential return of 57.12% based on the average RVMD price forecast.
Analyzing the RVMD fundamentals
Gross Profit Margin for this corporation currently stands at -179.13% with Operating Profit Margin at -880.32%, Pretax Profit Margin comes in at -763.77%, and Net Profit Margin reading is -764.23%. To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.34 and Total Capital is -0.4. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 41.86 points at the first support level, and at 40.65 for the second support level. However, for the 1st resistance point, the stock is sitting at 43.72, and for the 2nd resistance point, it is at 44.37.
Ratios To Look Out For
It’s worth pointing out that Revolution Medicines Inc [NASDAQ:RVMD]’s Current Ratio is 14.24. On the other hand, the Quick Ratio is 14.24, and the Cash Ratio is 1.82. Considering the valuation of this stock, the price to sales ratio is 10613.25, the price to book ratio is 4.61.
Transactions by insiders
Recent insider trading involved Cislini Jeff, General Counsel, that happened on Jan 21 ’25 when 2406.0 shares were sold. Officer, JEFFREY TODD CISLINI completed a deal on Jan 21 ’25 to buy 2406.0 shares. Meanwhile, Chief Operating Officer Horn Margaret A sold 4329.0 shares on Dec 16 ’24.
